Zobrazeno 1 - 10
of 259
pro vyhledávání: '"Ih, Chang"'
Autor:
John H Krystal, John M Kane, Christoph U Correll, David P Walling, Matthew Leoni, Sridhar Duvvuri, Shrinal Patel, Ih Chang, Philip Iredale, Lillian Frohlich, Stacey Versavel, Pamela Perry, Raymond Sanchez, John Renger
Publikováno v:
The Lancet. 400:2210-2220
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c12dc5168ae8c2fa7d4fdc431bc4004b
https://doi.org/10.1016/s0140-6736(22)01990-0
https://doi.org/10.1016/s0140-6736(22)01990-0
Autor:
Ih Chang, Ludwig Kappos, Gavin Giovannoni, Peter A Calabresi, Alfred Sandrock, Wenting Cheng, Shan Xiao, Katherine Riester, Shibeshih Belachew, Aaron Deykin, Bing Zhu
Publikováno v:
Multiple Sclerosis Journal. 28:2263-2273
Background: Overall Disability Response Score (ODRS) is a composite endpoint including Expanded Disability Status Scale, Timed 25-foot Walk, and 9-Hole Peg Test, designed to quantify both disability improvement and worsening in multiple sclerosis (MS
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7d0869f2a8fb4363bd552342a2773894
https://doi.org/10.1177/13524585221114997
https://doi.org/10.1177/13524585221114997
Autor:
Rachel Gurrell, Ih Chang, Ann Dandurand, Sridhard Duvvuri, Amy Guigliano, Gina Pastino, Theresa Pham, Stacey Versavel, Gabriel Jacobs, Koshar Safai Pour, Rob Zuiker, Raymond Sanchez, John Renger
Publikováno v:
Sunday, April 23.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::717304e923339ec5e2bee2905b4e768a
https://doi.org/10.1212/wnl.0000000000202097
https://doi.org/10.1212/wnl.0000000000202097
Publikováno v:
Journal of Clinical Pharmacology
Natalizumab is approved for multiple sclerosis treatment at a dose of 300 mg every 4 weeks. Extended‐interval dosing of natalizumab has been proposed as a strategy to mitigate the risk of progressive multifocal leukoencephalopathy, but the efficacy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::07a6774fe173e7172ef373c4176e5345
http://europepmc.org/articles/PMC7891569
http://europepmc.org/articles/PMC7891569
Autor:
Robert C. Bucelli, Manjit McNeill, Shafeeq Ladha, Angela Genge, Stephanie Fradette, Ivan Nestorov, John Ravits, Philip Van Damme, Roger Lane, Christopher J McDermott, Jonathan Glass, Merit Cudkowicz, Laura Fanning, C. Frank Bennett, Heiko Runz, Ih Chang, Hani Houshyar, Toby A. Ferguson, Alfred Sandrock, Alan Pestronk, Danielle Graham, Timothy M. Miller, Randall G. Trudell, Nazem Atassi, Peter M. Andersen, François Salachas, Nicholas J. Maragakis, Albert L. Ludolph, Pamela J. Shaw, Lorne Zinman, Alexander McCampbell
Publikováno v:
New England Journal of Medicine. 383:109-119
Background Tofersen is an antisense oligonucleotide that mediates the degradation of superoxide dismutase 1 (SOD1) messenger RNA to reduce SOD1 protein synthesis. Intrathecal administratio...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cd89d37b574703a54dc8fa55df6264a4
https://doi.org/10.1056/nejmoa2003715
https://doi.org/10.1056/nejmoa2003715
Autor:
Catherine E. Watson, Nicole Weissbach, Lise Kjems, Surya Ayalasomayajula, Yiming Zhang, Ih Chang, Mohamad Navab, Susan Hama, Greg Hough, Srinivasa T. Reddy, Daniel Soffer, Daniel J. Rader, Alan M. Fogelman, Alison Schecter
Publikováno v:
Journal of Lipid Research, Vol 52, Iss 2, Pp 361-373 (2011)
L-4F, an apolipoprotein A-I (apoA-I) mimetic peptide (also known as APL180), was administered daily by either intravenous (IV) infusion for 7 days or by subcutaneous (SC) injection for 28 days in patients with coronary heart disease in two distinct c
Externí odkaz:
https://doaj.org/article/bba86b6dfe5740d985bc87e52468c718
Autor:
Diego Cadavid, Michelle Mellion, Raymond Hupperts, Keith R Edwards, Peter A Calabresi, Jelena Drulović, Gavin Giovannoni, Hans-Peter Hartung, Douglas L Arnold, Elizabeth Fisher, Richard Rudick, Sha Mi, Yi Chai, Jie Li, Yiwei Zhang, Wenting Cheng, Lei Xu, Bing Zhu, Susan M Green, Ih Chang, Aaron Deykin, Sarah I Sheikh, Eduardo Agüera Morales, Abdullatif Al Khedr, Radek Ampapa, Rafael Arroyo, Martin Belkin, Robert Bonek, Alexey Boyko, Ruggero Capra, Diego Centonze, Pierre Clavelou, Marc Debouverie, Jelena Drulovic, Keith Edwards, Nikos Evangelou, Evgeniy Evdoshenko, Oscar Fernández, Victoria Fernández Sánchez, Mark Freedman, Steven Freedman, Waldemar Fryze, Antonio Garcia-Merino, Mira Gavric-Kezic, Angel Ghezzi, Olivier Gout, Luigi Grimaldi, Barry Hendin, Hanka Hertmanowska, Rogier Hintzen, Pavel Hradilek, Jan Ilkowski, Evelina Ivashinenkova, Guillermo Izquierdo, Francois Jacques, Gabor Jakab, Farit Khabirov, Gabriela Klodowska-Duda, Samuel Komoly, Smiljana Kostic, Ivana Kovarova, Marcelo Kremenchuzky, Christopher Laganke, Yves LaPierre, Maciej Maciejowski, Francois Grand Maison, Girolama Alessandra Marfia, Sergio Martínez Yélamos, Eva Meluzinova, Xavier Montalban, Ronald Murray, Robert Naismith, Scott Newsome, Viet Nguyen, Delia Oreja, Gabriel Pardo, Elena Pasechnik, Francesco Patti, Andrzej Potemkowski, Semen Prokopenko, Peiqing Qian, Alfredo Rodríguez-Antigüedad, Howard Rossman, Csilla Rozsa, Fernando Sánchez López, Krzysztof Selmaj, Eli Silber, Adam Stepien, Anna Stepniewska, Maciej Swiat, Gordana Toncev, Ayman Tourbah, Tatyana Trushnikova, Antonio Uccelli, Marta Vachova, Martin Valis, Laszlo Vecsei, Sandrine Wiertlewski, Mauro Zaffaroni, Tomasz Zielinski
Publikováno v:
Lancet Neurology, 18(9), 845-856. Elsevier Science
Summary Background Opicinumab is a human monoclonal antibody against LINGO-1, an inhibitor of oligodendrocyte differentiation and axonal regeneration. Previous findings suggested that opicinumab treatment might enhance remyelination in patients with
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::07aa5a507f0c6b885918964f0fe4abe5
https://doi.org/10.1016/s1474-4422(19)30137-1
https://doi.org/10.1016/s1474-4422(19)30137-1
Publikováno v:
Proceedings of the National Academy of Sciences of the United States of America, 1978 Mar 01. 75(3), 1451-1455.
Externí odkaz:
https://www.jstor.org/stable/68019
Autor:
Hsu, Ih Chang, Stoner, Gary D., Autrup, Herman, Trump, Benjamin F., Selkirk, James K., Harris, Curtis C.
Publikováno v:
Proceedings of the National Academy of Sciences of the United States of America, 1978 Apr 01. 75(4), 2003-2007.
Externí odkaz:
https://www.jstor.org/stable/68143
Publikováno v:
Proceedings of the National Academy of Sciences of the United States of America, 1979 Oct 01. 76(10), 5336-5339.
Externí odkaz:
https://www.jstor.org/stable/70445